OTCMKTS:RCPIQ Rock Creek Pharmaceuticals Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Rock Creek Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0016 0.00 (0.00 %) (As of 09/29/2020 12:00 AM ET) Add Compare Share Today's Range$0.00Now: $0.00▼$0.0050-Day Range N/A52-Week Range$0.00Now: $0.00▼$0.01Volume175 shsAverage Volume758,290 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta3.45 ProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestSocial Media Rock Creek Pharmaceuticals, Inc., a pharmaceutical development company, focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its lead compound is Anatabine citrate, a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics, with a mechanism of action distinct from other anti-inflammatory drugs available, such as biologics, steroids, and non-steroidal anti-inflammatories. The company was formerly known as Star Scientific, Inc. and changed its name to Rock Creek Pharmaceuticals, Inc. in June 2014. Rock Creek Pharmaceuticals, Inc. is headquartered in Sarasota, Florida. On September 27, 2016, Rock Creek Pharmaceuticals, Inc., along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Rock Creek Pharmaceuticals. Previous Next 2.3 Community Rank Outperform VotesRock Creek Pharmaceuticals has received 98 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRock Creek Pharmaceuticals has received 116 “underperform” votes. (Add your “underperform” vote.)Community SentimentRock Creek Pharmaceuticals has received 54.21% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Rock Creek Pharmaceuticals and other stocks. Vote “Outperform” if you believe RCPIQ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RCPIQ will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRock Creek Pharmaceuticals does not currently pay a dividend.Dividend GrowthRock Creek Pharmaceuticals does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rock Creek Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.89% of the stock of Rock Creek Pharmaceuticals is held by insiders. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:RCPIQ Previous SymbolNASDAQ:RCPI CUSIPN/A CIK776008 Webwww.rockcreekpharmaceuticals.com Phone844-727-0727Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees5 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $0.0016 0.00 (0.00 %) (As of 09/29/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive RCPIQ News and Ratings via Email Sign-up to receive the latest news and ratings for RCPIQ and its competitors with MarketBeat's FREE daily newsletter. Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) Frequently Asked Questions How has Rock Creek Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)? Rock Creek Pharmaceuticals' stock was trading at $0.0005 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RCPIQ shares have increased by 220.0% and is now trading at $0.0016. View which stocks have been most impacted by COVID-19. Are investors shorting Rock Creek Pharmaceuticals? Rock Creek Pharmaceuticals saw a decrease in short interest in the month of August. As of August 14th, there was short interest totaling 200 shares, a decrease of 99.5% from the July 30th total of 39,700 shares. Based on an average daily volume of 631,300 shares, the days-to-cover ratio is presently 0.0 days. View Rock Creek Pharmaceuticals' Short Interest. Who are some of Rock Creek Pharmaceuticals' key competitors? Some companies that are related to Rock Creek Pharmaceuticals include Actelion (ALIOF), STADA Arzneimittel (STDAF), Canopy Growth (CGC), Cronos Group (CRON), USANA Health Sciences (USNA), Aphria (APHA), Aphria (APHA), Tilray (TLRY), Aurora Cannabis (ACB), Canopy Rivers (RIV), Chromadex (CDXC), Mediwound (MDWD), Charlie's (CHUC), Natural Alternatives International (NAII) and Happiness Biotech Group (HAPP). View all competitors. Who are Rock Creek Pharmaceuticals' key executives? Rock Creek Pharmaceuticals' management team includes the following people: Dr. Michael John Mullan MBBS (M.D., ), Ph.D., Chairman, Chief Exec. Officer and Pres (Age 62)Dr. Curtis Wright IV, Sr. VP and Medical & Clinical Director (Age 70) What is Rock Creek Pharmaceuticals' stock symbol? Rock Creek Pharmaceuticals trades on the OTCMKTS under the ticker symbol "RCPIQ." How do I buy shares of Rock Creek Pharmaceuticals? Shares of RCPIQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Rock Creek Pharmaceuticals' stock price today? One share of RCPIQ stock can currently be purchased for approximately $0.00. What is Rock Creek Pharmaceuticals' official website? The official website for Rock Creek Pharmaceuticals is www.rockcreekpharmaceuticals.com. How can I contact Rock Creek Pharmaceuticals? Rock Creek Pharmaceuticals' mailing address is 2040 WHITFIELD AVE. SUITE 300, SARASOTA FL, 34243. The company can be reached via phone at 844-727-0727 or via email at [email protected] This page was last updated on 9/30/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
